RUNX2 and breast cancer: These studies altogether define the transcription factor RUNX2 as pro-migratory, pro-invasive and pro-angiogenic, in addition to its role in promoting the early steps of tumorigenesis in breast cancer and driving the metastatic bone disease in prostate and breast cancer.